harpethcapital.com

What It Is

Harpeth Capital is a middle-market investment bank founded in 1999 and headquartered in Nashville, USA. Its clients are not ordinary payment merchants, but mid-sized companies, founder-led businesses, management teams, and boards of directors seeking advisory services for major capital transactions. The website states that it has completed 125+ transactions with a total value of more than $6 billion, with a notable presence in the healthcare sector.

Core Capabilities

Its services cover M&A advisory, capital raising, general financial advisory, and financial restructuring, with an emphasis on “senior professionals participating in every engagement.” In healthcare, Harpeth Capital focuses on provider-based services, tech-enabled services, healthcare IT, behavioral health, revenue cycle management, and healthcare-related business services. Its transaction examples include fund placement, private growth capital, mezzanine debt, convertible note financing, company sales, and majority equity investments.

Pricing and Compliance

The website does not disclose advisory fees, success fees, financing commissions, or minimum transaction sizes, so actual costs are likely quoted on a project-by-project basis. On the compliance side, the privacy policy under the name Harpeth Securities mentions compliance with the Patriot Act, KYC, and anti-money-laundering rules, and also discloses Form CRS, regulatory actions, a business continuity plan, and FINRA links. This indicates the presence of securities-business-related regulatory disclosures, though the specific registration scope and license status should still be verified through FINRA and other channels.

Pros and Cons

Its strengths include a clear middle-market positioning, quantifiable transaction experience, a strong healthcare industry network, and a long-term advisory model that supports clients from pre-transaction relationship building through post-transaction support. Its weaknesses are limited information transparency, with no public disclosure of fees or detailed engagement processes. It is also not a payment gateway, acquiring institution, or fintech API platform, and does not offer capabilities such as payment methods, settlement cycles, or developer integrations.

Who It’s For and Access from China

It is better suited to U.S. or cross-border mid-sized companies with needs in M&A, financing, fund placement, or capital structure optimization, especially healthcare-related companies. It is not suitable for users looking for online payments, cross-border acquiring, wallets, or business payment APIs. Access from mainland China is not addressed in the main content, so its availability is unknown.